EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 5th, 2024 • Century Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This Executive Employment Agreement (the “Agreement”), dated September 13, 2024, is made and entered into by and between CENTURY THERAPEUTICS, INC., a Delaware corporation (the “Company”) and Chad Cowan (“Executive”), and will become effective as of October, 1 2024 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 5th, 2024 • Century Therapeutics, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This Executive Employment Agreement (the “Agreement”), dated September 20th, 2024, is made and entered into by and between CENTURY THERAPEUTICS, INC., a Delaware corporation (the “Company”) and Morgan Conn (“Executive”), and will become effective on October 14, 2024 (the “Effective Date”).
CENTURY THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN PERFORMANCE-BASED RESTRICTED STOCK UNIT GRANT NOTICE AND AWARD AGREEMENTPerformance-Based Restricted Stock Unit Grant Agreement • November 5th, 2024 • Century Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Century Therapeutics, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), hereby grants to the individual listed below (“Participant”) the target number of restricted stock units set forth below (the “Restricted Stock Units”). The Restricted Stock Units described in this Restricted Stock Unit Grant Notice (the “Grant Notice”) are subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan.
